Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy

Annals of Pharmacotherapy

Volumn 43, Issue 9, 2009, Pages 1419-1425

  Burry, Lisa D ^a   Tung, David D ^b,c   Hallett, David ^d   Bailie, Toni ^b   Carvalhana, Virginia ^b   Lee, David ^d   Ramganesh, Steve ^b   Richardson, Robert ^e   Mehta, Sangeeta ^b   Lapinsky, Stephen E ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b Pediatric Oral and Maxillofacial Surgery   (Canada)

^c Medisystems Pharmacy   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

ACD A; Citrate; CRRT; Dialysis; Regional anticoagulation

Indexed keywords

ACID CITRATE DEXTROSE; CALCIUM ION; GLUCONATE CALCIUM;

ACUTE LEUKEMIA; ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DIALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; FILTER; HUMAN; HYPOCALCEMIA; INTENSIVE CARE UNIT; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC ALKALOSIS; METABOLIC PARAMETERS; PRIORITY JOURNAL;

ADULT; AGED; ALKALOSIS; ANTICOAGULANTS; CALCIUM GLUCONATE; CITRIC ACID; CRITICAL ILLNESS; FEMALE; GLUCOSE; HOSPITALS, UNIVERSITY; HUMANS; HYPOCALCEMIA; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES;

EID: 69949102059     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M182     Document Type: Article

References (25)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554
2. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-526 (Pubitemid 23121799)
3. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C, and ADQI Workgroup. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002;62:1855-1863 (Pubitemid 35286296)
4. Mehta RL, Letteri JM. Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 1999;19:377-382
5. Meyer MM. Renal replacement therapies. Crit Care Clinics 2000;16:29-58.
6. Oudemans-van Straaten HM, Wester JPJ, de Pont ACJM, Schetz MR. Anticoagulation in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 2006;32:188-202.
7. Cutts M, Thomas A, Kishn R. Transfusion requirements during continuous veno-venous haemofiltration: the importance of filter life. Intensive Care Med 2000;26:1694-1697
8. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000;355:26-30. (Pubitemid 30416991)
9. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit "downtime" on uremic control during continuous veno-venous haemofiltration. Intensive Care Med 2003;29:575-578
10. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M. Renal replacement therapy in patients with acute renal failure. A systematic review. JAMA 2008;299:793-805.
11. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005;20:155-161 (Pubitemid 41219636)
12. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005;67:2361-2367 (Pubitemid 41623398)
13. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-981
14. Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 2007;11:218. (Pubitemid 351984863)
15. Gabutti L, Marone C, Colucci G, Duchini F, Schönholzer C. Citrate anticoagulation in continuous venovenous hemofiltration: a metabolic challenge. Intensive Care Med 2002;28:1419-1425
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829
17. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22: 707-710 (Pubitemid 26254283)
18. Meier-Kriesche H, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-752 (Pubitemid 32299711)
19. Tobe SW, Aujla P, Walele AA, et al. A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 2003;18: 121-129 (Pubitemid 36759164)
20. Dorval M, Madore F, Courteau S, Leblanc M. A novel citrate anticoagulation regimen for continuous venovenous hemofiltration. Intensive Care Med 2003;29:1186-1189 (Pubitemid 36918567)
21. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-265 (Pubitemid 38253417)
22. Hofmann RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Renal Failure 2002;24:325-335
23. Cointault O, Kamar N, Boires P, et al. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial solutions. Nephrol Dial Transplant 2004;19:171-178 (Pubitemid 38072629)
24. Oudemans-van Straaten H, Bosman R, Koopmans M, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009;37:545-552
25. Demirjian S, Teo BW, Paganini E. Alkalemia during continuous renal replacement therapy and mortality in critically ill patients. Crit Care Med 2008;36:1513-1517 (Pubitemid 351620659)